Viví Ann Flørenes
- Oncology top 1%
- Cancer-related Molecular Pathways 19
- Cancer Research top 2%
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 10
- Molecular Biology top 2%
- Melanoma and MAPK Pathways 19
- Cell death mechanisms and regulation 11
- Cell Biology top 2%
-
- Ovarian cancer diagnosis and treatment 14
-
- Cancer Research and Treatments 10
-
- Neuroblastoma Research and Treatments 8
-
- Sarcoma Diagnosis and Treatment 8
- Co-authors
- Gunhild M. MælandsmoØystein FodstadBen DavidsonRuth HolmRobert S. KerbelJoyce M. SlingerlandOla MyklebostJanusz Rak
- Partner nations
- NorwayUnited StatesCanada
In The Last Decade
Viví Ann Flørenes
106 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 111
- Oncology 2.2k
- Cancer Research 1.0k
- Immunology and Allergy 343
- Molecular Biology 3.5k
- Cell Biology 603
Countries citing papers authored by Viví Ann Flørenes
This map shows the geographic impact of Viví Ann Flørenes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viví Ann Flørenes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viví Ann Flørenes more than expected).
Fields of papers citing papers by Viví Ann Flørenes
This network shows the impact of papers produced by Viví Ann Flørenes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viví Ann Flørenes. The network helps show where Viví Ann Flørenes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Viví Ann Flørenes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 19 | |
| 2 | 2016 | 10 | |
| 3 | 2011 | 2 | |
| 4 | 2010 | 40 | |
| 5 | 2009 | 19 | |
| 6 | 2008 | 35 | |
| 7 | 2008 | 21 | |
| 8 | 2006 | 62 | |
| 9 | 2006 | 88 | |
| 10 | 2005 | 22 | |
| 11 | 2005 | 27 | |
| 12 | 2004 | 35 | |
| 13 | 2004 | 90 | |
| 14 | 2004 | 30 | |
| 15 | 2004 | 46 | |
| 16 | Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases. | 2002 | 17 |
| 17 | 1997 | 154 | |
| 18 | 1997 | 114 | |
| 19 | 散在性悪性黒色腫の発癌におけるpRb/p16/cdk4/サイクリンD1経路の関与 | 1996 | 4 |
| 20 | 1994 | 166 |
About Viví Ann Flørenes
Viví Ann Flørenes is a scholar working on Oncology, Reproductive Medicine and Immunology and Allergy, having authored 108 papers that have together received 5.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (19 papers), Cancer-related Molecular Pathways (19 papers), Ovarian cancer diagnosis and treatment (14 papers), Cell death mechanisms and regulation (11 papers), Cancer Research and Treatments (10 papers), Cell Adhesion Molecules Research (10 papers), Neuroblastoma Research and Treatments (8 papers) and Sarcoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (1.0k citations) and Immunology and Allergy (343 citations). Viví Ann Flørenes has collaborated with scholars based in Norway, United States and Canada. Frequent co-authors include Gunhild M. Mælandsmo, Øystein Fodstad, Ben Davidson, Ruth Holm, Robert S. Kerbel, Joyce M. Slingerland, Ola Myklebost, Janusz Rak, Jahn M. Nesland and Brad St. Croix. Their work appears in journals such as Nature Medicine, The Journal of Cell Biology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.